Phase III Study of GSK1278863 in Japanese Non-dialysis (ND) and Peritoneal Dialysis (PD) Subjects With Renal Anemia

NCT02791763 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

355

Enrollment

INDUSTRY

Sponsor class

Conditions

Anaemia

Interventions

DRUG: 1 to 4 mg tablets of GSK1278863
DRUG: 6 mg GSK1278863 tablet
DRUG: Epoetin beta pegol

Sponsor

GlaxoSmithKline